Characterization of histamine releasing factors in diisocyanate-induced occupational asthma.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Toxicology

• Publication date

  1996-07-17

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/0300-483X(96)03376-8PMID 8711735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD8+ T cells specific to the exogenous antigen. Mode of antigen recognition and possible implication in immunosuppression.

  1995cited by this paper
• Monocyte chemotactic protein-2, monocyte chemotactic protein-3, and fibroblast-induced cytokine. Three new chemokines induce chemotaxis and activation of basophils.

  1994cited by this paper
• Regulation of MCP-1/JE gene expression during monocytic differentiation.

  1994cited by this paper
• Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine

  1994cited by this paper
• CD8 T-cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate.

  1994cited by this paper
• Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.

  1994cited by this paper
• Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects.

  1994cited by this paper
• Monocyte chemotactic proteins MCP‐1, MCP‐2, and MCP‐3 are major attractants for human CD4+ and CD8+ T lymphocytes

  1994cited by this paper
• Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES.

  1994cited by this paper
• Antigen-specific stimulation of histamine releasing factors in diisocyanate-induced occupational asthma.

  1994cited by this paper
• Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo.

  1994cited by this paper
• Nature of the ligand recognized by a hapten- and carrier-specific, MHC-restricted T cell receptor.

  1993cited by this paper
• Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta

  1993cited by this paper
• Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules.

  1993cited by this paper
• The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production

  1993cited by this paper
• The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates.

  1993cited by this paper
• Production of granulocyte-macrophage colony-stimulating factor but not IL-3 by normal and neoplastic human B lymphocytes.

  1992cited by this paper
• Monocyte chemotactic protein 1 is a potent activator of human basophils

  1992cited by this paper
• Monocyte chemotactic and activating factor is a potent histamine- releasing factor for human basophils

  1992cited by this paper
• Effect of cessation of exposure to toluene diisocyanate (TDI) on bronchial mucosa of subjects with TDI-induced asthma.

  1992cited by this paper
• Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils.

  1992cited by this paper
• Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi.

  1992cited by this paper
• Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma.

  1992cited by this paper
• Synthetic peptides anchor T cell-specific TNP epitopes to MHC antigens.

  1992cited by this paper
• Enzyme‐Linked Immunosorbent Assays

  1992cited by this paper
• Allergic rhinitis to ragweed pollen. II. Modulation of histamine-releasing factor production by specific immunotherapy.

  1992cited by this paper
• The cell biology of antigen processing and presentation.

  1991cited by this paper
• The characteristics of antigen define the cellular source and kinetics of histamine-releasing factor induced by human peripheral-blood mononuclear cells.

  1991cited by this paper
• Increase in numbers of CD8 positive lymphocytes and eosinophils in peripheral blood of subjects with late asthmatic reactions induced by toluene diisocyanate.

  1991cited by this paper
• Current protocols in immunology

  1991cited by this paper
• Histamine releasing factors and cytokine-dependent activation of basophils and mast cells.

  1991cited by this paper
• Properties of the novel proinflammatory supergene "intercrine" cytokine family.

  1991cited by this paper
• Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES

  1990cited by this paper
• Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma.

  1990cited by this paper
• ELISA for human IgE antibody to subtilisin A (Alcalase): correlation with RAST and skin test results with occupationally exposed individuals.

  1990cited by this paper
• Specific serum antibodies against isocyanates: association with occupational asthma.

  1989cited by this paper
• The effect of preseasonal immunotherapy on the production of histamine-releasing factor (HRF) by mononuclear cells from patients with seasonal asthma: results of a double-blind, placebo-controlled, randomized study.

  1989cited by this paper
• Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity.

  1989cited by this paper
• Cellular origin of histamine-releasing factor produced by peripheral blood mononuclear cells.

  1989cited by this paper
• Histamine-releasing factors and IgE heterogeneity.

  1988cited by this paper
• Pulmonary and immunologic evaluation of foundry workers exposed to methylene diphenyldiisocyanate (MDI).

  1988cited by this paper
• IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.

  1988cited by this paper
• The magnitude of the spontaneous production of histamine-releasing factor (HRF) by lymphocytes in vitro correlates with the state of bronchial hyperreactivity in patients with asthma.

  1987cited by this paper
• Chronic asthma due to toluene diisocyanate.

  1986cited by this paper
• A basophil-activating factor from human T lymphocytes.

  1984cited by this paper
• Immunologic cross-reactivity between different albumin-bound isocyanates.

  1983cited by this paper
• Diverse profiles of immunoreactivity in toluene diisocyanate (TDI) asthma.

  1981cited by this paper
• Histamine-releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human mononuclear cells.

  1979cited by this paper
• Chemical characterization of isocyanate-protein conjugates.

  1979cited by this paper
• Use of tolylene diisocyanate for the preparation of a peroxidase-labelled antibody conjugate. Quantitation of the amount of diisocyanate bound.

  1973cited by this paper

• Lung Gene Expression Suggests Roles for Interferon-Stimulated Genes and Adenosine Deaminase Acting against RNA-1 in Pathologic Responses to Diisocyanate.

  2024cites this paper
• Historical Aspects of Occupational Asthma

  2021cites this paper
• The Cell Research Trends of Asthma: A Stem Frequency Analysis of the Literature

  2018cites this paper
• Connecting glutathione with immune responses to occupational methylene diphenyl diisocyanate exposure.

  2013cites this paper
• Pro/Con debate: is occupational asthma induced by isocyanates an immunoglobulin E‐mediated disease?

  2010cites this paper
• Histamine Release and Inflammatory Cell Infiltration in Airway Mucosa in Methylene Diphenyl Diisocyanate (MDI)-Induced Occupational Asthma

  2008cites this paper
• Vetenskapligt underlag för hygieniska gränsvärden. : 22

  2008cites this paper
• Th2 Cytokines in Skin Draining Lymph Nodes and Serum IgE Do Not Predict Airway Hypersensitivity to Intranasal Isocyanate Exposure in Mice.

  2007cites this paper
• Diisocyanate conjugate and immunoassay characteristics influence detection of specific antibodies in HDI‐exposed workers

  2007cites this paper
• Isocyanate exposure and respiratory health effects in the spray painting industry

  2007cites this paper
• Allerjik dermatozların tedavisinde diğer immun modülatörlere karşı steroidler

  2006cites this paper
• Occupational asthma caused by exposure to low-molecular-weight chemicals.

  2003cites this paper
• Pathogenesis of occupational asthma

  2003cites this paper
• Cellular aspects of occupational asthma : Immunological studies in isocyanate exposed subjects Prepared by the National Heart and Lung

  2003cites this paper
• Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma.

  2002cites this paper
• Recent developments in diisocyanate asthma

  2001cites this paper
• Scientific Basis for Swedish Occupational Standards XXII

  2001cites this paper
• Why are some low-molecular-weight agents asthmagenic.

  2000cites this paper
• Toxicologic considerations in the diagnosis of occupational asthma.

  1999cites this paper
• Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-alpha by peripheral mononuclear cells of workers with occupational asthma.

  1998cites this paper
• Indirect assessment of 4,4'-diphenylmethane diisocyanate (MDI) exposure by evaluation of specific humoral immune responses to MDI conjugated to human serum albumin.

  1998cites this paper
• Immunologic aspects of isocyanate asthma: IL-1 beta, IL-3, IL-4, sIL2R, and sICAM-1.

  1998cites this paper
• Cytokines and asthma.

  1998cites this paper
• Allergic reactions to workplace allergens.

  1997cites this paper